reference/12253474

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253474

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	4368
issn	0006-4971 1528-0020
issueIdentifier	20
pageRange	4361-4368
publicationName	Blood
startingPage	4361
bibliographicCitation	Garg RJ, Kantarjian H, O'Brien S, Quintás-Cardama A, Faderl S, Estrov Z, Cortes J. The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up. Blood. 2009 Nov 12;114(20):4361–8. PMID: 19729517; PMCID: PMC3952810.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_386cf7e222997ebd16e954edf7d1c580 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4190883552be9e16fc03bddc09e5f0ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8636-1071 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d486b0352524567a03a648ed075996a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8c1de7da4deb440ed2ecc8697edce38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbef71c6c9ee38c2d2fb7df759bcb6c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_550fcc5addca292095bb24f38832bb39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2179b74e09e09468d620914757116d27
date	2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19729517 https://doi.org/10.1182/blood-2009-05-221531 https://pubmed.ncbi.nlm.nih.gov/PMC3952810
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971 https://portal.issn.org/resource/ISSN/1528-0020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up
discusses	http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0021333
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019008Q000187 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D015464Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437088 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7055 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 70.